EP 1259236 A1 20021127 - TYROSINE KINASE INHIBITORS
Title (en)
TYROSINE KINASE INHIBITORS
Title (de)
TYROSINKINASE-INHIBITOREN
Title (fr)
INHIBITEURS DE TYROSINE-KINASE
Publication
Application
Priority
- US 0105567 W 20010221
- US 18502400 P 20000225
Abstract (en)
[origin: WO0162252A1] The present invention relates to compounds which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions, such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.
IPC 1-7
A61K 31/4355; A61K 31/4365; A61K 31/437; A61K 31/4375; A61P 35/00; C07D 471/04; C07D 519/00
IPC 8 full level
A61K 31/4355 (2006.01); A61K 31/4365 (2006.01); A61K 31/437 (2006.01); A61K 31/4375 (2006.01); A61K 45/00 (2006.01); A61K 45/06 (2006.01); A61P 3/10 (2006.01); A61P 17/02 (2006.01); A61P 17/06 (2006.01); A61P 19/00 (2006.01); A61P 19/02 (2006.01); A61P 27/02 (2006.01); A61P 29/00 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01); C07D 471/04 (2006.01); C07D 519/00 (2006.01); C07D 209/00 (2006.01); C07D 221/00 (2006.01)
CPC (source: EP)
A61K 45/06 (2013.01); A61P 3/10 (2017.12); A61P 17/02 (2017.12); A61P 17/06 (2017.12); A61P 19/00 (2017.12); A61P 19/02 (2017.12); A61P 27/02 (2017.12); A61P 29/00 (2017.12); A61P 35/00 (2017.12); A61P 43/00 (2017.12); C07D 471/04 (2013.01)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated extension state (EPC)
AL LT LV MK RO SI
DOCDB simple family (publication)
WO 0162252 A1 20010830; AU 3981401 A 20010903; AU 778417 B2 20041202; CA 2400923 A1 20010830; EP 1259236 A1 20021127; EP 1259236 A4 20041103; JP 2003523390 A 20030805
DOCDB simple family (application)
US 0105567 W 20010221; AU 3981401 A 20010221; CA 2400923 A 20010221; EP 01914424 A 20010221; JP 2001561318 A 20010221